Essential role for ICSBP in the in vivo development of murine CD8α+ dendritic cells

被引:258
作者
Aliberti, J
Schulz, O
Pennington, DJ
Tsujimura, H
Sousa, CRE
Ozato, K
Sher, A
机构
[1] NIAID, Immunobiol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA
[2] NICHHD, Lab Mol Growth Regulat, NIH, Bethesda, MD 20892 USA
[3] Canc Res United Kingdom, London Res Inst, Immunobiol & Lymphocyte Mol Biol Labs, London, England
关键词
D O I
10.1182/blood-2002-04-1088
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Interferon (IFN) consensus sequence-binding protein (ICSBP) is an important transcription factor regulating proinflammatory cytokine production and the development of mononuclear phagocytes in vitro. Here we analyzed the role of ICSBP in the in vivo differentiation of 3 major subsets of murine dendritic cells (DCs). We found that ICSBP is predominantly expressed by the CD8alpha(+) subset, and more important, that ICSBP-/- mice have a profound and selective deficiency in CD8alpha(+) IDEC205(+) DCs in lymphold tissues. Studies using wild-type/ICSBP-/- chimeras revealed that this defect in CD8alpha(+) DC development is intrinsic to bone marrow-derived progenitors and not dependent on ICSBP expression in the nonhemopoietic compartment. Because DC precursor frequencies are unaltered in the bone marrow of ICSBP-/- mice, ICSBP appears to function by regulating CD8alpha(+) DC differentiation downstream from the generation of common DC progenitors. Although CD8alpha(-) DCs are present in normal numbers in ICSBP-/- animals, up-regulation of CD40, CD80, and major histocompatibility complex (MHC) class II expression was found to be impaired in this subset after in vivo microbial stimulation. Together these results demonstrate that ICSBP is critically required for the in vivo differentiation of CD8alpha(+) DCs and may also influence the functional maturation of the CD8alpha(-) subsets. (C) 2003 by The American Society of Hematology.
引用
收藏
页码:305 / 310
页数:6
相关论文
共 38 条
[1]   CCR5 provides a signal for microbial induced production of IL-12 by CD8α+ dendritic cells [J].
Aliberti, J ;
Sousa, CRE ;
Schito, M ;
Hieny, S ;
Wells, T ;
Huffnagle, GB ;
Sher, A .
NATURE IMMUNOLOGY, 2000, 1 (01) :83-87
[2]   Transcription factor PU.1 is necessary for development of thymic and myeloid progenitor-derived dendritic cells [J].
Anderson, KL ;
Perkin, H ;
Surh, CD ;
Venturini, S ;
Maki, RA ;
Torbett, BE .
JOURNAL OF IMMUNOLOGY, 2000, 164 (04) :1855-1861
[3]   Mouse type IIFN-producing cells are immature APCs with plasmacytoid morphology [J].
Asselin-Paturel, C ;
Boonstra, A ;
Dalod, M ;
Durand, I ;
Yessaad, N ;
Dezutter-Dambuyant, C ;
Vicari, A ;
O'Garra, A ;
Biron, C ;
Brière, F ;
Trinchieri, G .
NATURE IMMUNOLOGY, 2001, 2 (12) :1144-1150
[4]   Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte-macrophage colony-stimulating factor-treated mice [J].
Björck, P .
BLOOD, 2001, 98 (13) :3520-3526
[5]   Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures [J].
Brasel, K ;
De Smedt, T ;
Smith, JL ;
Maliszewski, CR .
BLOOD, 2000, 96 (09) :3029-3039
[6]   CD8α+ dendritic cells originate from the CD8α- dendritic cell subset by a maturation process involving CD8α, DEC-205, and CD24 up-regulation [J].
del Hoyo, GM ;
Martín, P ;
Arias, CF ;
Marín, AR ;
Ardavín, C .
BLOOD, 2002, 99 (03) :999-1004
[7]   CD8+ but not CD8- dendritic cells cross-prime cytotoxic T cells in vivo [J].
den Haan, JMM ;
Lehar, SM ;
Bevan, MJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (12) :1685-1695
[8]   Interferon (IFN) consensus sequence-binding protein, a transcription factor of the IFN regulatory factor family, regulates immune responses in vivo through control of interleukin 12 expression [J].
Giese, NA ;
Gabriele, L ;
Doherty, TM ;
Klinman, DM ;
TadesseHeath, L ;
Contursi, C ;
Epstein, SL ;
Morse, HC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (09) :1535-1546
[9]   PU.1 is required for myeloid-derived but not lymphoid-derived dendritic cells [J].
Guerriero, A ;
Langmuir, PB ;
Spain, LM ;
Scott, EW .
BLOOD, 2000, 95 (03) :879-885
[10]   Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene [J].
Holtschke, T ;
Lohler, J ;
Kanno, Y ;
Fehr, T ;
Giese, N ;
Rosenbauer, F ;
Lou, J ;
Knobeloch, KP ;
Gabriele, L ;
Waring, JF ;
Bachmann, MF ;
Zinkernagel, RM ;
Morse, HC ;
Ozato, K ;
Horak, I .
CELL, 1996, 87 (02) :307-317